
Former "Bachelorette" JoJo Fletcher and her husband, Jordan Rodgers, welcomed their first baby via emergency cesarean section days before Christmas, the couple announced.
Fletcher wrote on Instagram that she went for a sonogram appointment on Tuesday and "found out we needed to deliver via emergency c section that day."
Their baby girl, Romy Blair Rodgers, was born at 5:37 p.m. on Tuesday.
Prince William, Kate Middleton and kids spread cheer on Christmas
"What a whirlwind these last couple of days have been but in the most magical way," she wrote.
"Merry Christmas to us," she said.
How celebrities are celebrating Christmas 2025
Fletcher's best friend from "The Bachelor," Becca Tilley, commented, "Our little Romy girl!!!!! Love y’all so much! So proud of you!!!!!"
Rodgers, a college football analyst, won Fletcher's final rose on season 12 of the "Bachelorette," which aired in 2016. They tied the knot in 2022. Fletcher announced her pregnancy in August, saying they were welcoming a "rainbow baby."
LATEST POSTS
- 1
Surging measles cases are 'fire alarm' warning that other diseases could be next - 2
10 Picturesque Campgrounds That Will Raise Your Outside Involvement with American - 3
Poland identifies two Ukrainian suspects in railway sabotage blast - 4
Amy Poehler's podcast is a hit. It's also a Trojan horse for talking about women and aging. - 5
Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
The most effective method to Pick the Right Material Organization: Fundamental Tips
Medtronic has 'significant firepower' for multiple acquisitions, executives say
Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
Magnetic fossils may reveal ancient creature's internal 'GPS system'
Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
It's been 20 years since MTV's golden couple split. These producers saw it all unravel.
7 Popular Vacation destinations In China
Is relief in sight? Flu season still brutal but cases are declining.
Merck sees over $5 billion opportunity in Cidara's experimental flu drug













